HDL PARTICLE MEASUREMENTS - IMPACT FOR DIAGNOSIS AND THERAPY

被引：10

作者：

BARD, JM

FRUCHART, JC

机构：

[1] INST PASTEUR, SERLIA, 1 RUE PROFESSEUR CALMETTE, F-59019 LILLE, FRANCE

[2] INST PASTEUR, INSERM, UNITE 325, F-59019 LILLE, FRANCE

来源：

关键词：

D O I：

10.1016/0009-9120(93)90030-A

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：65 / 68

页数：4

共 26 条

[1] ALAUPOVIC P, 1982, RES CLIN LAB, V12, P3
[2] SUBPOPULATIONS OF APOLIPOPROTEIN-A-I IN HUMAN HIGH-DENSITY LIPOPROTEINS THEIR METABOLIC PROPERTIES AND RESPONSE TO DRUG-THERAPY
ATMEH, RF
SHEPHERD, J
PACKARD, CJ
[J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 751 (02) : 175 - 188
[3] CHOLESTEROL EFFLUX FROM CULTURED ADIPOSE-CELLS IS MEDIATED BY LPAI PARTICLES BUT NOT BY LPAI-AII PARTICLES
BARBARAS, R
PUCHOIS, P
FRUCHART, JC
AILHAUD, G
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 142 (01) : 63 - 69
[4] EFFECT OF PRAVASTATIN, AN HMG COA REDUCTASE INHIBITOR, AND CHOLESTYRAMINE, A BILE-ACID SEQUESTRANT, ON LIPOPROTEIN PARTICLES DEFINED BY THEIR APOLIPOPROTEIN COMPOSITION
BARD, JM
PARRA, HJ
DOUSTEBLAZY, P
FRUCHART, JC
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (03): : 269 - 273
[5] A MULTICENTER COMPARISON OF THE EFFECTS OF SIMVASTATIN AND FENOFIBRATE THERAPY IN SEVERE PRIMARY HYPERCHOLESTEROLEMIA, WITH PARTICULAR EMPHASIS ON LIPOPROTEINS DEFINED BY THEIR APOLIPOPROTEIN COMPOSITION
BARD, JM
PARRA, HJ
CAMARE, R
LUC, G
ZIEGLER, O
DACHET, C
BRUCKERT, E
DOUSTEBLAZY, P
DROUIN, P
JACOTOT, B
DEGENNES, JL
KELLER, U
FRUCHART, JC
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (05): : 498 - 503
[6] BARD JM, IN PRESS COMP EFFECT
[7] BREWER HB, 1990, DISORDERS HDL, P51
[8] CAMBIEN F, 1990, CIRCULATION, V348, P1380
[9] CASTRO GR, 1984, J LIPID RES, V25, P58
[10] CHEUNG MC, 1982, J LIPID RES, V23, P747